M. A. Jakupec, M. Galanski, V. B. Arion, C. G. Hartinger, and B. K. Keppler, Antitumor metal compounds: more than theme and variations, Dalton Trans, pp.183-194, 2008.

L. Kelland, The resurgence of platinum-based cancer chemotherapy, Nat. Rev. Cancer, vol.7, pp.573-584, 2007.

S. Van-zutphen and J. Reedijk, Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity, Coord. Chem. Rev, vol.249, pp.2845-2853, 2005.

C. G. Hartinger, N. Metzler-nolte, and P. J. Dyson, Challenges and Opportunities in the Development of Organometallic Anticancer Drugs, Organometallics, vol.31, pp.5677-5685, 2012.

N. P. Barry and P. J. Sadler, Exploration of the medical periodic table: towards new targets, Chem. Commun, pp.49-5106, 2013.

P. V. Turner, T. Brabb, C. Pekow, and M. A. Vasbinder, Administration of substances to laboratory animals: routes of administration and factors to consider, J. Am. Assoc. Lab. Anim. Sci, vol.50, pp.600-613, 2011.

N. J. Wheate, S. Walker, G. E. Craig, and R. Oun, The status of platinum anticancer drugs in the clinic and in clinical trials, Dalton Trans, pp.39-8113, 2010.

T. C. Johnstone, G. Y. Park, and S. J. Lippard, Understanding and Improving Platinum Anticancer Drugs ? Phenanthriplatin, Anticancer Res, vol.34, pp.471-476, 2014.

G. R. Newkome, D. C. Panteleo, W. E. Puckett, P. L. Ziefle, and W. A. Deutsch, Complexes of palladium(II), platinum(II), copper(II), cobalt(II), and zinc(II) chlorides with 6,6?-dimethyl-2,2?-dipyridyl, J. Inorg. Nucl. Chem, vol.43, pp.1529-1531, 1981.

N. Garelli and P. Vierling, Incorporation of new amphiphilic perfluoroalkylated bipyridine platinum and palladium complexes into liposomes: stability and structure-incorporation relationships, Biochim. Biophys. Acta, pp.41-48, 1127.

N. Garelli and P. Vierling, Synthesis and characterization of amphiphilic platinum and palladium complexes linked to perfluoroalkylated side-chain disubstituted bipyridines, Inorg. Chim. Acta, vol.194, pp.247-253, 1992.

G. L. Edwards, D. S. Black, G. B. Deacon, and L. P. Wakelin, In vitro and in vivo studies of neutral cyclometallated complexes against murine leukaemias, Can. J. Chem, vol.83, pp.980-989, 2005.

G. L. Edwards, D. S. Black, G. B. Deacon, and L. P. Wakelin, Effect of charge and surface area on the cytotoxicity of cationic metallointercalation reagents, Can. J. Chem, vol.83, pp.969-979, 2005.

V. Vo, Z. G. Kabuloglu-karayusuf, S. W. Carper, B. L. Bennett, and C. Evilia, Novel 4,4?-diether-2,2?-bipyridine cisplatin analogues are more effective than cisplatin at inducing apoptosis in cancer cell lines, Bioorg. Med. Chem, vol.18, pp.1163-1170, 2010.

K. E. Elwell, C. Hall, S. Tharkar, Y. Giraud, B. Bennett et al., A fluorine containing bipyridine cisplatin analog is more effective than cisplatin at inducing apoptosis in cancer cell lines, Bioorg. Med. Chem, vol.14, pp.8692-8700, 2006.

N. Garelli, P. Vierling, J. L. Fischel, and G. Milano, Cytotoxic activity of new amphiphilic perfluoroalkylated bipyridine platinum and palladium complexes incorporated into liposomes, Eur. J. Med. Chem, vol.28, pp.235-242, 1993.

M. Klajner, P. Hebraud, C. Sirlin, C. Gaiddon, and S. Harlepp, DNA Binding to an Anticancer Organo-Ruthenium Complex, J. Phys. Chem. B, pp.114-14041, 2010.

B. Boff, C. Gaiddon, and M. Pfeffer, Cancer Cell Cytotoxicity of Cyclometalated Compounds Obtained with Osmium(II) Complexes, Inorg. Chem, vol.52, pp.2705-2715, 2013.

C. Kaes, A. Katz, M. W. Hosseini, and . Bipyridine, The Most Widely Used Ligand. A Review of Molecules Comprising at Least Two 2,2?-Bipyridine Units, Chem. Rev, vol.100, pp.3553-3590, 2000.

A. Zucca, G. L. Petretto, S. Stoccoro, M. A. Cinellu, M. Manassero et al., Cyclometalation of 2,2?-Bipyridine. Mono-and Dinuclear C,N Platinum(II) Derivatives, Organometallics, vol.28, pp.2150-2159, 2009.

G. Minghetti, A. Doppiu, A. Zucca, S. Stoccoro, M. A. Cinellu et al., Palladium(II) and platinum(II)-C(3)-substituted 2,2?-bipyridines, Chem. Heterocycl. Compd, vol.35, pp.992-1000, 1999.

G. Minghetti, S. Stoccoro, M. A. Cinellu, B. Soro, and A. Zucca, Activation of a C-H Bond in a Pyridine Ring. Reaction of 6-Substituted 2,2?-Bipyridines with Methyl and Phenyl Platinum(II) Derivatives: N?,C(3)-?Rollover? Cyclometalation, Organometallics, vol.22, pp.4770-4777, 2003.

F. Cocco, M. A. Cinellu, G. Minghetti, A. Zucca, S. Stoccoro et al., Intramolecular C(sp2)-H Bond Activation in 6,6?-Dimethoxy-2,2?-Bipyridine with Gold(III). Crystal and Molecular Structure of the First N?,C(3) ?Rollover? Cycloaurated Derivative, Organometallics, vol.29, pp.1064-1066, 2010.

G. L. Petretto, J. P. Rourke, L. Maidich, S. Stoccoro, M. A. Cinellu et al., Organometallics, vol.31, pp.2971-2977, 2012.

L. Maidich, G. Zuri, S. Stoccoro, M. A. Cinellu, M. Masia et al., Mesoionic Complexes of Platinum(II) Derived from ?Rollover? Cyclometalation: A Delicate Balance between Pt-C(sp3) and Pt-C(sp2) Bond Cleavage as a Result of Different Reaction Conditions, Organometallics, vol.32, pp.438-448, 2013.

A. Zucca, D. Cordeschi, L. Maidich, M. I. Pilo, E. Masolo et al., Rollover Cyclometalation with 2-(2?-Pyridyl)quinoline, Inorg. Chem, vol.52, pp.7717-7731, 2013.

L. Maidich, G. Zuri, S. Stoccoro, M. A. Cinellu, and A. Zucca, Assembly of symmetrical and unsymmetrical platinum(II) rollover complexes with bidentate phosphine ligands, Dalton Trans, vol.43, pp.14806-14815, 2014.

L. Maidich, G. Dettori, S. Stoccoro, M. A. Cinellu, J. P. Rourke et al., Synthesis, biological evaluation, and molecular docking studies on the DNA binding interactions of platinum(II) rollover complexes containing phosphorus donor ligands, 817?828. (29), vol.34, pp.456-465, 2015.

A. Esmaeilbeig, H. Samouei, S. Abedanzadeh, and Z. Amirghofran, Synthesis, characterization and antitumor activity study of some cyclometalated organoplatinum(II) complexes containing aromatic Ndonor ligands, J. Organomet. Chem, vol.696, pp.3135-3142, 2011.

M. Fereidoonnezhad, M. Niazi, Z. Ahmadipour, T. Mirzaee, Z. Faghih et al., Cyclometalated platinum(II) complexes comprising 2-(diphenylphosphino)pyridine and various thiolate ligands: synthesis, spectroscopic characterization, and biological activity, Eur. J. Inorg. Chem, 2017.

H. Samouei, M. Rashidi, and F. W. Heinemann, Cyclometalated platinum(II) complexes containing monodentate phosphines: antiproliferative study, J. Iran. Chem. Soc, vol.11, pp.1207-1216, 2014.

I. M. El-mehasseb, M. Kodaka, T. Okada, T. Tomohiro, K. Okamoto et al., Platinum (II) complex with cyclometalating 2-phenylpyridine ligand showing high cytotoxicity against cisplatin-resistant cell, J. Inorg. Biochem, vol.84, pp.157-158, 2001.

T. Okada, I. M. El-mehasseb, M. Kodaka, T. Tomohiro, K. Okamoto et al., Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance, J. Med. Chem, vol.44, pp.4661-4667, 2001.

M. Fereidoonnezhad, B. Kaboudin, T. Mirzaee, R. Babadi-aghakhanpour, M. Golbon-haghighi et al., Cyclometalated Platinum(II) Complexes Bearing Bidentate O,O?-Di(alkyl)-dithiophosphate Ligands: Photoluminescence and Cytotoxic Properties, Organometallics, vol.36, pp.1707-1717, 2017.

M. Frik, J. Fernandez-gallardo, O. Gonzalo, V. Mangas-sanjuan, M. Gonzalez-alvarez et al., Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties, J. Med. Chem, vol.58, pp.5825-5841, 2015.

J. Ruiz, N. Cutillas, C. Vicente, M. D. Villa, G. Lopez et al., New Palladium(II) and Platinum(II) Complexes with the Model Nucleobase 1-Methylcytosine: Antitumor Activity and Interactions with DNA, Inorg. Chem, vol.44, pp.7365-7376, 2005.

J. Ruiz, J. Lorenzo, C. Vicente, G. Lopez, J. M. Lopez-de-luzuriaga et al., A. New Palladium(II) and Platinum(II) Complexes with 9-Aminoacridine: Structures, Luminescence, Theoretical Calculations, and Antitumor Activity, vol.47, pp.6990-7001, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01469439

J. Ruiz, V. Rodriguez, N. Cutillas, A. Espinosa, and M. J. Hannon, Novel C,N-chelate platinum(II) antitumor complexes bearing a lipophilic ethisterone pendant, J. Inorg. Biochem, vol.105, pp.525-531, 2011.

J. Ruiz, V. Rodriguez, N. Cutillas, G. Lopez, and D. Bautista, Acetonimine and 4-Imino-2-methylpentan-2-amino Platinum(II) Complexes: Synthesis and in Vitro Antitumor Activity, Inorg. Chem, vol.47, pp.10025-10036, 2008.

D. Ma and C. Che, A bifunctional platinum(II) complex capable of intercalation and hydrogen-bonding interactions with DNA: Binding studies and cytotoxicity, Coord. Chem. Rev, vol.9, issue.42, pp.84-95, 2003.

M. Frezza, Q. P. Dou, Y. Xiao, H. Samouei, M. Rashidi et al., In Vitro and In Vivo Antitumor Activities and DNA Binding Mode of Five Coordinated Cyclometalated Organoplatinum(II) Complexes Containing Biphosphine Ligands, J. Med. Chem, vol.54, pp.6166-6176, 2011.

D. A. Vezzu, Q. Lu, Y. Chen, and S. Huo, Cytotoxicity of cyclometalated platinum complexes based on tridentate NCN and CNN-coordinating ligands: Remarkable coordination dependence, J. Inorg. Biochem, vol.134, pp.49-56, 2014.

D. J. Daigle, A. B. Pepperman, and S. L. Vail, Synthesis of a monophosphorus analog of hexamethylenetetramine, J. Heterocycl. Chem, vol.11, pp.407-408, 1974.

R. Romeo and L. M. Scolaro, 2?:6?,2?-Terpyridine)-methylplatinum(II) chloride and (1,10-phenanthroline)-methylchloroplatinum(II), vol.2

H. Becker and . Organicum, Organic Chemistry Basic Laboratory Course, vol.880, p.pp, 1977.

G. Lukas, S. D. Brindle, and P. Greengard, Route of absorption of intraperitoneally administered compounds, J. Pharmacol. Exp. Ther, vol.178, pp.562-566, 1971.

G. L. Cohen, W. R. Bauer, J. K. Barton, and S. J. Lippard, Binding of cis-and trans-dichlorodiammineplatinum(II) to DNA: Evidence for unwinding and shortening of the double helix, Science, vol.203, pp.1014-1016, 1979.

P. M. Takahara, A. C. Rosenzweig, C. A. Frederick, and S. J. Lippard, Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin, Nature, vol.377, pp.649-652, 1995.

H. Huang, L. Zhu, B. R. Reid, G. P. Drobny, and P. B. Hopkins, Solution structure of a cisplatin-induced DNA interstrand cross-link, Science, vol.270, pp.1842-1845, 1995.

S. Zorbas-seifried, M. A. Jakupec, N. V. Kukushkin, M. Groessl, C. G. Hartinger et al., Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands, Mol. Pharmacol, vol.71, pp.357-365, 2007.

J. Reedijk, Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?, Chem. Rev, vol.99, pp.2499-2510, 1999.

N. Farrell, L. R. Kelland, J. D. Roberts, and M. Van-beusichem, Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action, Cancer Res, vol.52, pp.5065-5072, 1992.

C. Korch, M. A. Spillman, T. A. Jackson, B. M. Jacobsen, S. K. Murphy et al., DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination, Gynecol. Oncol, vol.127, pp.241-248, 2012.

A. E. Egger, C. Rappel, M. A. Jakupec, C. G. Hartinger, P. Heffeter et al., Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells, J. Anal. At. Spectrom, pp.51-61, 2009.

C. S. Allardyce, P. J. Dyson, D. J. Ellis, and S. L. Heath, decane): a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells, Chem. Commun, pp.1396-1397, 2001.

D. S. Black, G. B. Deacon, and G. L. Edwards, Observations on the mechanism of halogen-bridge cleavage by unidentate ligands in square planar palladium and platinum complexes, Aust. J. Chem, vol.47, pp.217-227, 1994.

A. Zucca, L. Maidich, L. Canu, G. L. Petretto, S. Stoccoro et al., Rollover-Assisted C(sp2)-C(sp3) Bond Formation, Chem. -Eur. J, vol.20, pp.5501-5510, 2014.

M. Snow and E. Tiekink, Crystal structure of dichloro(N-methyl-2,2?-bipyridylium)platinum(II), C 11 H 10 Cl 2 N 2 Pt, Z. Kristallogr, pp.148-150, 0198.

C. S. Allardyce and P. J. Dyson, Metal-based drugs that break the rules, Dalton Trans, vol.45, pp.3201-3209, 2016.

E. Wexselblatt, E. Yavin, and D. Gibson, Cellular interactions of platinum drugs, Inorg. Chim. Acta, vol.393, pp.75-83, 2012.

M. Groessl and C. G. Hartinger, Anticancer metallodrug research analytically painting the ?omics? picture-current developments and future trends, Anal. Bioanal. Chem, pp.405-1791, 2013.

C. G. Hartinger, A. Casini, C. Duhot, Y. O. Tsybin, L. Messori et al., Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: Relevance to antitumor activity, J. Inorg. Biochem, vol.102, pp.2136-2141, 2008.

S. M. Meier, Y. O. Tsybin, P. J. Dyson, B. K. Keppler, and C. G. Hartinger, Fragmentation methods on the balance: unambiguous top-down mass spectrometric characterization of oxaliplatin-ubiquitin binding sites, Anal. Bioanal. Chem, vol.402, pp.2655-2662, 2012.

M. V. Babak, S. M. Meier, A. A. Legin, M. S. Adib-razavi, A. Roller et al., Am(m)ines Make the Difference: Organoruthenium Am(m)ine Complexes and Their Chemistry in Anticancer Drug Development, Chem. -Eur. J, vol.19, pp.4308-4318, 2013.

S. M. Meier, M. Hanif, W. Kandioller, B. K. Keppler, and C. G. Hartinger, Biomolecule binding vs. anticancer activity: Reactions of Ru(arene)[(thio)pyr(id)one] compounds with amino acids and proteins, J. Inorg. Biochem, vol.108, pp.91-95, 2012.

J. D. Holding, W. E. Lindup, C. Van-laer, G. C. Vreeburg, V. Schilling et al., Phase I trial of a cisplatinalbumin complex for the treatment of cancer of the head and neck, Br. J. Clin. Pharmacol, vol.33, 1992.

, Inorg. Chem, vol.57, pp.2851-2864, 2018.

J. Wehner, G. Horneck, and H. Buecker, Plasmids as test system for the detection of DNA strand breaks, NATO ASI Ser., Ser. A, vol.243, pp.49-52, 1993.

J. Ruiz, C. Vicente, C. De-haro, and A. Espinosa, Synthesis and Antiproliferative Activity of a C,N-Cycloplatinated(II) Complex with a Potentially Intercalative Anthraquinone Pendant, Inorg. Chem, vol.50, 2011.

A. A. Recio-despaigne, J. G. Da-silva, P. R. Da-costa, R. G. Santos, and H. Beraldo, ROS-mediated cytotoxic effect of copper(II) hydrazone complexes against human glioma cells, Molecules, vol.19, pp.17202-17220, 2014.

A. Zakovska, O. Novakova, Z. Balcarova, U. Bierbach, N. Farrell et al., DNA interactions of antitumor trans

, Eur. J. Biochem, vol.254, pp.547-557, 1998.

S. Benosman, I. Gross, N. Clarke, A. G. Jochemsen, K. Okamoto et al., Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis, Cell Death Differ, vol.14, 2007.

C. Licona, M. Spaety, A. Capuozzo, M. Ali, R. Santamaria et al., A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin, Oncotarget, vol.8, pp.2568-2584, 2017.

Y. Von-grabowiecki, P. Abreu, O. Blanchard, L. Palamiuc, S. Benosman et al., Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63. eLife 2016, 5, e10528. (76) Cubillos-Ruiz, J. R, vol.168, pp.692-706, 2017.

M. J. Chow, C. Licona, G. Pastorin, G. Mellitzer, W. H. Ang et al., Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistance, Chem. Sci, vol.7, pp.4117-4124, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02365338

D. Y. Wong, W. W. Ong, and W. H. Ang, Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes, Angew. Chem., Int. Ed, vol.54, pp.6483-6487, 2015.

X. Wang, Q. Guo, L. Tao, L. Zhao, Y. Chen et al., E platinum, a newly synthesized platinum compound, induces apoptosis through ROS-triggered ER stress in gastric carcinoma cells, Mol. Carcinog, vol.56, pp.218-231, 2017.

T. Zou, C. Lok, Y. M. Fung, and C. Che, Luminescent organoplatinum(II) complexes containing bis(N-heterocyclic carbene) ligands selectively target the endoplasmic reticulum and induce potent photo-toxicity, Chem. Commun, vol.49, pp.5423-5425, 2013.

J. Ye and C. Koumenis, ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis, Curr. Mol. Med, vol.9, pp.411-416, 2009.

Q. Zheng, J. Ye, and J. Cao, Translational regulator eIF2? in tumor, Tumor Biol, vol.35, pp.6255-6264, 2014.